School of Medicine
Showing 1,001-1,100 of 2,431 Results
-
Jaya Karnani, MD
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Jaya Karnani practices family medicine in Bay Valley Medical Group’s Hayward office. She attended medical school at Kasturba Medical College in India and completed her residency at the Fort Wayne Medical Education Program in Indiana.
Dr. Karnani is board-certified by the American Board of Family Medicine. She speaks English and Hindi. Dr. Karnani joined Bay Valley Medical Group in 2009. In her spare time, she enjoys cooking, traveling, reading and watching movies. -
Maya M. Kasowski
Assistant Professor of Pathology, of Medicine (Pulmonary, Allergy and Critical Care Medicine) and, by courtesy, of Genetics
BioI am a clinical pathologist and assistant professor in the Departments of Medicine, Pathology, and Genetics (by courtesy) at Stanford. I completed my MD-PhD training at Yale University and my residency training and a post-doctoral fellowship in the Department of Genetics at Stanford University. My experiences as a clinical pathologist and genome scientist have made me passionate about applying cutting-edge technologies to primary patient specimens in order to characterize disease pathologies at the molecular level. The core focus of my lab is to study the mechanisms by which genetic variants influence the risk of disease through effects on intermediate molecular phenotypes.
-
Michele Kastelein
Clinical Assistant Professor, Medicine - Vaden Health Center
Current Research and Scholarly InterestsAt Stanford University School of Medicine, one of our major goals is to translate research insights into practical advances that enhance and prolong life. We foster a two-way transfer of knowledge between research laboratories and patient-care settings. Our faculty, staff, postdoctoral scholars and students engage in interdisciplinary efforts to turn this knowledge into therapies that treat or prevent disease.
-
Tamiko Robin Katsumoto MD, DipABLM
Clinical Associate Professor, Medicine - Immunology & Rheumatology
BioTamiko Katsumoto, MD, DipABLM is a Clinical Associate Professor in the Division of Immunology and Rheumatology at Stanford University and is board certified in lifestyle medicine. She earned her MD from the University of California, San Francisco. She completed her internal medicine residency and rheumatology fellowship at UCSF, including a postdoc in immunology. Deeply committed to human and planetary health, she is passionate about educating her patients, her colleagues, and the general public on the merits of sustainable whole food plant-centered diets as a strategy to both improve individual health and mitigate climate change and environmental degradation. She is fascinated by the impact of diet and lifestyle on inflammation, autoimmunity, and cancer. She directs the Rheumatology Oncology Clinic and serves as a co-director of the Stanford Immune Related Toxicity Working Group, a multidisciplinary group which aims to improve the quality of care of cancer patients on immune checkpoint inhibitors. She is involved in several clinical trials at Stanford and has spent time at Genentech, where she led several global clinical trials in immunology. She co-chaired the American College of Rheumatology Climate Change Task Force. She is working closely with the Stanford Doerr School of Sustainability and serves on the steering committee for the Center for Human and Planetary Health where she co-leads the Food Systems, Health and Environment Working Group.
-
Daniel Katz
Assistant Professor of Medicine (Computational Medicine)
BioDaniel Katz is an Assistant Professor of Medicine in the Stanford Center for Biomedical Informatics Research (BMIR) and the Cardiovascular Medicine Divisions. He practices as an Advanced Heart Failure and Transplant Cardiologist. He completed internal medicine residency at Massachusetts General Hospital, general cardiology training at Beth Israel Deaconess Medical Center, and then joined Stanford in 2021 for his advanced heart failure training. His research focuses on identifying the various pathophysiologic patterns and mechanisms that lead to the heterogeneous syndrome of heart failure. His efforts leverage high dimensional data in many forms including clinical phenotypes, plasma proteomics, metabolomics, and genetics. He is presently engaged in analysis of multi-omic data from the Molecular Transducers of Physical Activity Consortium (MoTrPAC) and the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program. His clinical interests include advanced heart failure, transplant cardiology, and mechanical circulatory support.
-
Gabriel Katz Wisel
Affiliate, Medicine - Primary Care and Population Health
BioI am an economist and data scientist working as a Social Science Research Scholar at the Geldsetzer Lab. I am also a Professor of Political Economy and Data Science at the University of Exeter, UK. I completed my PhD in Economics at the California Institute of Technology (Caltech).
-
Colonel Ronit Katz (Ben-Abraham)
Affiliate, Medicine - Primary Care and Population Health
BioColonel (CA) Ronit Katz, MD is The Surgeon General for the CA Guard and a consultant to NASA-Ames Medical Unit. During the current pandemic she has played a vital leadership role in California’s response to the evolving situation and received two NASA-Ames safety awards for her role in COVID -19 prevention.
Professor Katz is Board Certified in Preventive, Occupational and Environmental Medicine, and is a Fellow of the American College of Preventive Medicine.
Dr. Katz provides her expertise in occupational and environmental medicine to the CA WRIISC team.
Colonel (Dr.) Katz attended Tel Aviv University and The Weizmann Institute of Science in Israel at age 15. She graduated Magna cum Laude from Tel Aviv University, Sackler Medical School. She completed a fellowship in cancer research at Tufts-New England Medical Center, and later served as a Faculty Member at the Harvard University School of Public Health.
She is a recipient of Lawrence Livermore National Lab's (LLNL) “Certificate of Excellence” for outstanding performance in support of the Health Services Department, received the NASA Group Achievement Award, and was selected as one of the "Top Doctors in Silicon Valley."
In 2007, Dr. Katz received The American Medical Association’s (AMA) “Excellence in Medicine and Leadership Award.”
She serves on many boards and committees for local and national professional organizations, including serving in various senior and policy leadership roles in the AMA including Chair of AMA-IMGS Governing council and Delegate to HOD, and representing Stanford University Medical center for AMA-OMSS.
In 2018, Dr. Katz was a keynote speaker at the JMA International Conference on CBRNE/Disaster Preparedness/Counterterrorism in preparation for the Tokyo 2020 Olympics. In 2019 Col. Katz was the Key note speaker for Lawrence Livermore National Lab (LLNL) and her presentation was streamed live to other DOE facilities.
Colonel Katz is a national speaker and educator for The American College of Occupational & Environmental Medicine( ACOEM) and The New England Journal of Medicine Resident 360 programs.
Colonel Katz, MD is a Clinical Professor(Aff.) at Stanford University Medical Center where she was awarded the "Excellent Teacher Award." -
Masataka Kawana
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Kawana is the Medical Director of the Ambulatory Heart Failure and Cardiomyopathy Service in the Advanced Heart Failure program. He completed his internal medicine, cardiovascular medicine, and heart failure training at Stanford. He also completed a postdoctoral research fellowship under Dr. James Spudich in the Department of Biochemistry. He manages advanced heart failure patients in the clinic, CCU/heart failure service, and post-heart transplant/MCS service. His research interests are in the fundamental mechanisms of inherited cardiomyopathies, and he studies the effect of gene mutations on cardiac sarcomere function using cutting-edge biochemical and biophysical approaches, which would lead to the development of novel pharmacotherapy that directly modulates cardiac muscle protein. He is involved in multiple clinical trials for pharmacotherapy and novel device studies in heart failure and inherited cardiomyopathy.
-
Joshua Keefe, MD, PhD
Affiliate, Department Funds
Resident in MedicineBioJoshua Keefe is a resident physician in the Stanford Internal Medicine Residency as part of the Translational Investigator Program. Josh received his BS in Bioengineering from UCLA and subsequently completed a postbaccalaureate research fellowship at the Framingham Heart Study before obtaining his MD and PhD from the Baylor College of Medicine. Josh completed his PhD under the mentorship of Dr. Xander Wehrens studying the role of macrophage-mediated inflammation in postoperative atrial fibrillation.
-
Kevin R Keet
Clinical Assistant Professor, Medicine
BioDr. Keet is an award-winning medical educator and hospitalist at the Palo Alto VA and Stanford University Hospitals, where he serves as Associate Program Director for the Internal Medicine residency. His clinical practice is grounded in a commitment to empathetic, patient-centered care, and he brings that same orientation to his work with trainees, helping residents develop the clinical reasoning and humanism that define excellent internists. His scholarly interests sit at the intersection of medical education and artificial intelligence, with a particular focus on how physicians can be prepared to use AI tools thoughtfully while preserving the cognitive skills and human judgment that patients depend on.
-
Vanessa Kennedy
Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Kennedy is a board-certified hematologist and medical oncologist who specializes in the treatment of myeloid malignancies, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myelofibrosis (MF). She is an Assistant Professor in the Department of Medicine, Division of Blood and Marrow Transplantation & Cellular Therapy, at Stanford University School of Medicine.
Dr. Kennedy's research focuses on the use of clinical informatics and bioinformatics in understanding cancer biology and improving patient outcomes. She is also actively involved in interventional clinical trials. Her work has been supported by grant funding from the American Society of Clinical Oncology, the American Society of Hematology, and the Chan-Zuckerberg Foundation. -
Andreas Kerschbaumer
Postdoctoral Scholar, Immunology and Rheumatology
BioDr. Andreas Kerschbaumer is a postdoctoral scholar in the Division of Immunology and Rheumatology at Stanford University, conducting research in the Robinson and Khatri Labs. His work integrates clinical rheumatology with computational and systems immunology, applying meta-analytic techniques on transcriptomic datasets to uncover mechanisms of autoimmunity and improve therapeutic strategies in rheumatology.
He trained in internal medicine and rheumatology at the Medical University of Vienna, Department of Medicine III, Division of Rheumatology, where he also completed his PhD under Professors Smolen and Aletaha on treatment outcomes in inflammatory arthritis, followed by his habilitation on strategies to optimize the interpretation of clinical trial data in rheumatoid and psoriatic arthritis.
Dr. Kerschbaumer has been actively engaged with the European Alliance of Associations for Rheumatology (EULAR), contributing as Fellow, Methodologist, and Co-Methodologist to multiple international taskforces, including the 2019, 2022, and 2025 rheumatoid arthritis recommendations and the 2019 and 2023 psoriatic arthritis recommendations. He is currently a member of the EULAR Quality of Care Committee and serves as Co-Abstract Chair of the ACR Rheumatoid Arthritis abstract committee. -
Kian Keyashian
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioThe management of inflammatory bowel disease continues to evolve, with the introduction of biologic and small molecule therapies and new goals of treatment, with an emphasis on healing the bowel. My career goal since my graduation from IBD fellowship in 2012 has been to improve the outcomes and quality of life of patients with inflammatory bowel disease. In line with these goals, my research has focused investigating new noninvasive diagnostic test, finding factors early in the disease course that might predict a more aggressive disease course and need for different therapies, and investigating new promising effective medications with less side effects.
-
Ali Raza Khaki, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Khaki is a medical oncologist and clinical assistant professor at Stanford University School of Medicine.
In his clinical practice, he treats patients with all forms of genitourinary cancer, including kidney, bladder, prostate, and testicular. He also regularly attends on the inpatient oncology service at Stanford Hospital.
With each patient, he is devoted to providing exceptional, humanistic care and has been recognized throughout his career for his humanism. As a medical student, he was named to the national Gold Humanism Honor Society and he received the Reza Gandjei Humanism Award as a medical resident at UCSF.
His research interests include novel therapies for genitourinary cancers, with a focus on urothelial cancer outcomes. He is the site principal investigator for multiple clinical trails investigating new therapies for genitourinary cancers.
Dr. Khaki is also active working clinically in inpatient oncology and is a Unit Based Medical Director for G1, an oncology hospital unit and is the Director of Inpatient Oncology. In this role, he oversees the inpatient oncology teams, works closely with the cancer center to develop new transitions of care pathways from inpatient to outpatient and has co-led an inpatient oncology research group to study quality improvement, care delivery and end-of-life care for patients with cancer.
Dr. Khaki has earned honors and recognition from the American Association for Cancer Research, American Society of Clinical Oncology, Bladder Cancer Advocacy Network, Conquer Cancer Foundation, and other organizations.
He has authored numerous articles on topics such as immunotherapy for urothelial cancer, management of cancer patients with COVID-19, and utilization of end-of-life care by cancer patients. In addition, he is an editor for HemOnc.org and theMednet, a physician-only online community where members share clinical questions and answers. -
Saad A. Khan, MD
Associate Professor of Medicine (Oncology)
BioDr. Khan is a fellowship-trained cancer specialist with board certification in oncology and hematology. He is an assistant professor in the Department of Medicine, Division of Oncology.
Dr. Khan focuses on the treatment of head and neck cancers, advanced thyroid cancers, and neuroendocrine tumors. He recognizes the broad effects of these conditions on daily living and aims to develop personalized, comprehensive treatment plans that optimize health and quality of life.
Dr. Khan’s research interests include therapeutic clinical trials as well as ways to reduce toxicities that some patients may experience when receiving cancer treatment. His research activities include ongoing clinical trials of targeted and immune therapy for aggressive thyroid cancer.
He has published numerous articles on his research discoveries in peer-reviewed journals such as the JAMA Oncology, Investigational New Drugs, and others. Topics include new drug treatments for small cell lung cancer and for cancers of the head and neck, racial and gender disparities in certain types of cancer, and management of the potentially toxic effects of cancer therapies.
Dr. Khan is a member of the NRG Head and Neck Committee. NRG brings together internationally recognized groups (the first words in their names form the acronym “NRG”) to conduct cancer clinical research and share study results. The objective is to inform clinical decision making and healthcare policy worldwide.
Dr. Khan is a member of the ECOG Head and Neck Core and Thoracic Committees. ECOG (Eastern Cooperative Oncology Group) is part of one of the five groups of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN) Program.
He also is a member of the National Cancer Institute’s Central IRB for Early Phase Clinical Trials.
When not providing patient care or conducting research, Dr. Khan enjoys spending time with his family, hiking, and relaxing at the beach. -
Abha Khandelwal
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsCardiovascular disease in Pregnancy
Valvular Heart Disease
Cardiomyopathy
Pericardial disease
Heart Disease in South Asians
Women's Cardiovascular Disease -
Sarita Khemani
Clinical Associate Professor, Medicine
Current Research and Scholarly InterestsDr. Khemani’s scholarly work focuses on physiological reserve, biological aging, and healthy longevity, with an emphasis on developing multidimensional measures to better predict resilience, recovery, and health trajectories across the lifespan.
-
Amy Khokhar
Temporary Employee, Medicine - Med/Stanford Prevention Research Center
Casual - Non-Exempt, Stanford Center on LongevityCurrent Role at StanfordStanford Lifestyle Medicine Program Administrator
-
Nitasha Khullar, MD
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr. Nitasha Khullar is a board-certified, fellowship-trained rheumatologist at Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Division of Immunology and Rheumatology at Stanford University School of Medicine.
Dr. Khullar specializes in caring for people with autoimmune and inflammatory diseases that affect the joints, muscles, and immune system. She treats conditions like lupus, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, vasculitis, gout and other complex rheumatic disorders. She provides personalized care for each patient, focusing on early diagnosis and working closely with other medical specialists to help manage these diseases. She values shared decision-making and a patient-centric approach to her care.
Dr. Khullar’s work has been presented at national and international conferences, including the American College of Rheumatology and the American Association of Immunology. She has authored peer-reviewed publications in journals such as Viruses, Molecular Neurobiology, Age (Dordrecht, Netherlands), and Current Treatment Options in Rheumatology.
She is a member of the American College of Rheumatology. -
Kiran Khush, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Khush's clinical research interests include the evaluation of donors and recipients for heart transplantation; mechanisms of adverse outcomes after heart transplantation, including cardiac allograft vasculopathy and antibody-mediated rejection; and development of non-invasive diagnostic approaches for post-transplant monitoring.
-
Michaela Kiernan
Senior Research Scholar, Medicine - Med/Stanford Prevention Research Center
Current Research and Scholarly InterestsResearch interests include the design and experimental testing of innovative strategies to improve recruitment and retention of randomized clinical trials.
-
Joel Killen
Professor (Research) of Medicine (General Internal Medicine), Emeritus
Current Research and Scholarly InterestsMy research is focused on the development and evaluation of cigarette smoking prevention and cessation therapies and obesity prevention treatments for children, adolescents and adults.
-
Donghee Kim, MD, PhD
Social Science Research Scholar, Medicine - Med/Gastroenterology and Hepatology
BioI am a physician with specialized training in gastroenterology and hepatology. My research primarily focuses on clinical research into metabolic dysfunction-associated steatotic liver disease (MASLD), chronic liver diseases, and obesity-related gastrointestinal diseases, with a population-based study. In addition, my research has expanded to encompass cardiology, endocrinology, neurology, and psychiatry. I have extensive experience in large epidemiologic cohort studies as well as clinical trials. This work has resulted in over 300 published papers in prominent journals, including Gastroenterology, Journal of Hepatology, Gut, Hepatology, and Clinical Gastroenterology and Hepatology, with the author serving as first or corresponding author. These publications have been cited more than 22000 times with an H-index of 73.
-
Gloria S. Kim
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsAsian Health
Medical education
Health services delivery
Management of chronic disease
Patient and physician satisfaction -
Jackson Kim, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Kim is a Clinical Assistant Professor in the Division of Nephrology at Stanford Health Care.
Dr. Kim diagnoses and treats a range of conditions affecting the kidneys, including glomerulonephritis, nephrotic syndrome, chronic kidney disease, and genetic kidney disease. He creates a customized, comprehensive treatment plan for every patient he serves.
Dr. Kim has a keen research interest in glomerular kidney disease, particularly glomerulonephritis. He has authored manuscripts, conducted case studies, and published his work in several peer-reviewed journals. -
Juyong Brian Kim
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsThe lifetime risk of developing cardiovascular disease (CVD) is determined by the genetic makeup and exposure to modifiable risk factors. The Cardiovascular Link to Environmental ActioN (CLEAN) Lab is interested in understanding how various environmental pollutants (eg. tobacco, e-cigarettes, air pollution and wildfire) interact with genes to affect the transcriptome, epigenome, and eventually disease phenotype of CVD. The current focus is to investigate how different toxic exposures can adversely remodel the vascular wall leading to increased cardiac events. We intersect human genomic discoveries with animal models of disease, in-vitro and in-vivo systems of exposure, single-cell sequencing technologies to solve these questions. Additionally, we collaborate with various members of the Stanford community to develop biomarkers that will aid with detection and prognosis of CVD. We are passionate about the need to reduce the environmental effects on health through strong advocacy and outreach.
(http://kimlab.stanford.edu) -
Kaitlyn Kim
Masters Student in Translational Research and Applied Medicine, admitted Autumn 2025
Stanford Student Employee, Health PolicyCurrent Research and Scholarly InterestsCancer Immunotherapy, Solid Tumors, Early-Stage Neurodegeneration, Healthy Aging, Sleep Dysregulation.
-
Kyung Mi Kim
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioKyung Mi Kim, PhD, RN, is a Clinical Assistant Professor at Stanford University, School of Medicine. She has expertise in quantitative methods, including econometrics, large data analysis, and the evaluation of value-based payment policies. She is passionate about care models that lower the cost of high-quality care for frail, older surgical patients and their caregivers, partnering with leaders in health care, science, and technology to achieve the greatest impact.
-
Nathan Geonwoo Kim, MD, MS
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Nathan Geonwoo Kim is a board-certified, fellowship-trained transplant hepatologist with Stanford Health Care. He is also a clinical assistant professor in the Department of Medicine, Division of Gastroenterology & Hepatology at Stanford University School of Medicine.
Dr. Kim specializes in hepatology and liver transplantation (transplant hepatology). He cares for people with severe liver disease, such as cirrhosis, alcohol-associated hepatitis, and metabolic dysfunction-associated steatotic liver disease. Dr. Kim also provides personalized liver cancer care, which may include targeted therapies or liver transplantation to achieve the best possible outcomes.
With a Master of Science in epidemiology and clinical research, Dr. Kim studies hepatocellular carcinoma and outcomes in chronic liver disease. His research focuses on ways to deliver better, more equitable care to people with liver diseases.
Dr. Kim has published his findings in leading medical journals, including the Journal of Hepatology, Clinical Gastroenterology and Hepatology, and Cancer. He has also shared his expertise at national and international conferences, including Digestive Disease Week, The Liver Meeting, and the International Liver Congress. -
Paige Livingston, PA-C
Physician Assistant - Research, Medicine - Med/Blood and Marrow Transplantation
BioPaige has an undergraduate degree in Nutrition from Cal Poly, SLO and completed her Master’s degree in Physician Assistant Studies at Western University of Health Sciences in Southern California before moving to the bay area in November 2016 to join the Stanford Bone Marrow Transplant & Cancer Cell Therapy team. She believes in providing quality care with compassion, taking time to listen to patients and families and helping them navigate complex medical situations and decisions. She has lead the project for APP involvement in Bone Marrow Harvests and serves on the planning committee for a local APP Oncology conference. Her area of clinical practice is bone marrow transplantation and cancer cell therapy.
-
Seung K. Kim M.D., Ph.D.
KM Mulberry Professor, Professor of Developmental Biology, of Medicine (Endocrinology) and, by courtesy, of Pediatrics (Endocrinology)
Current Research and Scholarly InterestsPancreatic islets are essential for human health. We study the development and function of islet cells using modern methods in several model systems, including mice, pigs, human pancreas, primates, embryonic stem cells, and fruit flies. We have discovered critical factors required for islet development and mature islet cell function. These approaches have informed efforts to generate replacement islets, and provide immune protection of transplanted islets for diabetes.
-
Sun Kim, M.D. M.S.
Associate Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsWe are interested in studying the pathophysiological processes that contribute to glucose intolerance and type 2 diabetes mellitus. My current research focuses on characterizing pancreatic beta-cell function in populations with significant insulin resistance and vulnerability to developing diabetes: individuals with schizophrenia, morbid obesity, and history of gestational diabetes.
-
Yeuen Kim
Clinical Associate Professor, Medicine - Vaden Health Center
BioYeuen Kim MD MAS is an internal medicine physician with expertise in population health, medical humanities educational interventions, and working with vulnerable populations in urban settings. She trained at Brown University's Program in Liberal Medical Education and completed residency/chief residency at the Santa Clara Valley Medical Center in San Jose, CA. She has worked with vulnerable populations in ambulatory and mobile settings as a primary care attending and medical outreach physician, as well as completing a Masters' and fellowship in clinical research at UCSF's Department of Biostatistics and Epidemiology & SFGH DGIM, where she evaluated electronic referrals to subspecialty clinics from safety settings (Kim, Chen et al, JGIM 2009.) She worked with the SF and Santa Clara County public health departments to help reduce mortality and improve COVID19 and mpox mitigation, especially at congregate residential facilities through better ventilation, public-private collaboration, and addressing determinants of health for essential workers. Since 2013, she has facilitated art gallery-based workshops for physicians and learners to improve observation and communication skills. She co-leads narrative medicine and oncology workshops for students, residents (Edwards, Kim et al, BMJ Educ 2022) and faculty as a clinical associate professor in Primary care and population health.
-
Youn H Kim, MD
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology)
Current Research and Scholarly InterestsClinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.
-
Christian Kindermann
Research Engineer, Computational Medicine
Current Role at StanfordI am a research engineer specializing in semantic technologies (ontologies and knowledge graphs). My work focuses on helping life-science practitioners and researchers manage their data.
-
Abby C. King
David and Susan Heckerman Professor and Professor of Epidemiology & Population Health and of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsMy interests include applications of behavioral theory and social ecological approaches to achieve large scale changes impacting chronic disease prevention and control; expanding the reach and translation of evidence-based interventions through state-of-the-art technologies; exploring social and physical environmental influences on health; applying community participatory research perspectives to address health disparities; and policy-level approaches to health promotion/disease prevention.
-
Teri Klein
Professor (Research) of Biomedical Data Science, of Medicine (Computational Medicine) and, by courtesy, of Genetics
Current Research and Scholarly InterestsCo-founder, Pacific Symposium on Biocomputing
NIEHS, Site Visit Reviewer
NIH, Study Section Reviewer -
Samantha M.R. Kling
Quantitative Research Scientist, Medicine - Primary Care and Population Health
Current Role at StanfordQuantitative Research Scientist in the Evaluation Sciences Unit (ESU)
-
Joshua W. Knowles
Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsGenetic basis of coronary disease
Genetic basis of insulin resistance
Familial Hypercholesterolemia (FH) -
Joel Koh
Affiliate, Computational Medicine
BioJoel Koh is the Chief Technology Officer at One X Group, an AI and software company that designs and builds AI systems for businesses. With over a decade of experience at the intersection of technology and business transformation, he works with organizations to translate AI capabilities into practical, business-ready solutions.
Leveraging his technical and strategic background, Joel provides hands-on guidance in areas such as AI strategy development, software implementation, systems design, and technology adoption. His experience across large, complex organizations enables him to offer grounded, execution-focused advice that bridges the gap between emerging technology and real business needs.
He is also a Member of Technical Staff & AI Researcher at Stanford University's ARISE (AI Research and Science Evaluation) lab in San Francisco, California, where he works directly with leading AI labs including OpenAI, Google DeepMind, and Anthropic, contributing to independent research benchmarking frontier AI systems and evaluating their real-world performance against clinical and scientific reasoning standards. -
Matthew Kohrman
Associate Professor of Anthropology, and by courtesy, of Medicine (Stanford Prevention and Research Center) and Senior Fellow, by courtesy, at the Freeman Spogli Institute for International Studies
BioMatthew Kohrman’s research and writing bring anthropological methods to bear on the ways health, culture, and politics are interrelated. Focusing on the People's Republic of China, he engages various intellectual terrains such as governmentality, gender theory, political economy, critical science studies, narrativity, and embodiment. His first monograph, Bodies of Difference: Experiences of Disability and Institutional Advocacy in the Making of Modern China, raises questions about how embodied aspects of human existence, such as our gender, such as our ability to propel ourselves through space as walkers, cyclists and workers, become founts for the building of new state apparatuses of social provision, in particular, disability-advocacy organizations. Over the last decade, Prof. Kohrman has been involved in research aimed at analyzing and intervening in the biopolitics of cigarette smoking among Chinese citizens. This work, as seen in his recently edited volume--Poisonous Pandas: Chinese Cigarette Manufacturing in Critical Historical Perspectives--expands upon heuristic themes of his earlier disability research and engages in novel ways techniques of public health, political philosophy, and spatial history. More recently, he has begun projects linking ongoing interests at the intersection of phenomenology and political economy with questions regarding environmental attunement and the arts.
-
Qinqin Kong
Postdoctoral Scholar, General Internal Medicine
BioI am currently a Postdoctoral Scholar in the Departments of Medicine and Health Policy at Stanford University, after earning my PhD in Atmospheric Science from Purdue University. My research examines the physical drivers and societal impacts of extreme heat. My PhD work focused on how land–atmosphere interactions shape human heat stress and on the economic and energy impacts of increasing heat stress under climate change. At Stanford, my postdoctoral research focuses on the public health impacts of heat, particularly in low- and middle-income countries.
My ongoing projects include: (1) evaluating the effects of dry versus humid prenatal heat exposure on child stunting in India; and (2) developing a data-driven framework to address a longstanding question in heat-health research: how much should humidity factor into the measurement of human heat stress? My methodological expertise spans climate modeling, human biophysics modeling, and empirical causal inference. -
Michael Kozal
Professor of Medicine (Infectious Diseases)
BioDr. Kozal is a Professor of Medicine in the Division of Infectious Diseases and Geographic Medicine and is the Director of Operations for the Department of Medicine Clinical Research Hub. He previously served as Senior Associate Dean for Veteran Affairs at Stanford School of Medicine and Chief of Staff at VA Palo Alto Health Care System. Prior to coming to Stanford, he was a Professor of Medicine at Yale University School of Medicine and served as Associate Dean for Veteran Affairs at Yale University School of Medicine and the Chief of Staff at VA Connecticut Healthcare System.
Dr. Kozal is a translational researcher who has focused his research career on three areas: 1) investigating the genetic determinants of HIV and HCV drug resistance, 2) the development of new molecular methods to detect viral mutations, and 3) HIV and HCV clinical trials involving new drugs and diagnostic technology. Dr. Kozal is an expert in microarray and deep sequencing technology receiving patents for his work in genotyping. Dr. Kozal previously directed the Yale HIV Clinical Trials Group and has more than 20 years of experience in running clinical trials, serving as the principal investigator or site investigator on >40 HIV and Hepatitis C trials. He has served on multiple VA and NIH/NCI review panels and was a member of the DHHS/NIH Panel on Antiretroviral Guidelines for Adults and Adolescents from 2015-2024.
Dr. Kozal is currently serving as the overall Director of Operations for the Department of Medicine Clinical Research Hub. The key hub functions include research navigation, enhanced pre-award support for budgeting and submission strategy, streamlined contracting with research sponsors, a multisite clinical coordination center to coordinate and monitor complex studies, and a centralized digital platform for study design, data access, and analytics.
Dr. Kozal sees patients in the Infectious Diseases Clinic and the Valley Fever Clinic in Palo Alto. -
Fredric Kraemer
Gerald M. Reaven, MD, Professor of Endocrinology, Emeritus
Current Research and Scholarly InterestsOur research interests are in the general area of cellular lipid and lipoprotein metabolism. The work is aimed primarily at understanding the mechanisms regulating cholesterol and triglyceride accumulation in cells. We utilize a variety of techniques from cell biology, biochemistry, and molecular biology.
-
Daniel Kraft, MD
Adjunct Professor, Med/Hospital Medicine
BioDaniel Kraft is a Stanford and Harvard-trained physician-scientist, inventor, and entrepreneur with more than 25 years of experience across clinical practice, biomedical research, and healthcare innovation.
He earned his bachelor's degree in biochemistry from Brown University and his medical degree from Stanford University School of Medicine, completed the Harvard Combined Residency in Internal Medicine and Pediatrics, and went on to fellowships in hematology, oncology, and bone marrow transplantation at Stanford and a postdoctoral research fellowship in the laboratory of Irving L. Weissman. He went on to serve on clinical faculty at UCSF in pediatric bone marrow transplantation, and as NIH-funded research faculty at Stanford.
His academic research has spanned stem cell biology and regenerative medicine, stem cell–derived immunotherapies for cancer, and the bioengineering of human T-cell differentiation, with work published in journals including Nature and Science. He holds medical device, immunology, and stem cell–related patents, and is the inventor of the MarrowMiner, an FDA-cleared device for minimally invasive bone marrow harvesting.
Dr. Kraft is the Founder and Chair of NextMed Health (formerly Exponential Medicine), Founder of Digital.Health, and Managing Partner of Continuum Health Ventures, an early-stage fund focused on democratizing health and improving healthspan. A frequent voice on the future of medicine, he has delivered four TED and two TEDMED talks and keynotes worldwide. He is also a member of the inaugural class of the Aspen Institute Health Innovators Fellowship and the Kauffman Fellows Society. -
Beatrix Krause-Sorio
Senior Program Manager, Medicine - Med/Cardiovascular Medicine
Current Role at StanfordSenior Program Manager
-
Kristina Kudelko
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsDrugs and toxins-associated pulmonary arterial hypertension, clinical outcomes research, evaluating the long-term impacts of a standardized pulmonary vascular disease fellowship training program
-
Andre Kumar MD, MEd
Clinical Professor, Medicine
BioDr. Andre Kumar is a Clinical Professor in the Stanford Division of Hospital Medicine with a passion for improving patient care through Point-of-Care Ultrasound (POCUS), clinical research, and education. He earned his MD from Tulane University and completed his residency, chief residency, and a Master's in Education at Stanford University.
Dr. Kumar has extensive experience in creating, operationalizing, and leading multi-center clinical trials, including investigations related to POCUS, COVID-19 therapeutics, procedural safety, and the long-term health consequences of infections on the heart and lungs. He continues to conduct research and teach POCUS on a local and national level, and is committed to improving the science and education that underlie the next generation of diagnostic tools. Currently, his research focuses on the impact of artificial intelligence (AI) on numerous healthcare applications, particularly for the improving the accuracy of clinician diagnosis, evidence-based management, and medical imaging.
Dr. Kumar is also a committed educator and mentor to the next generation of physicians. His contributions to medical education have been recognized with several awards, including the Lawrence H. Mathers Award for Exceptional Commitment to Teaching (2023), the Henry J. Kaiser Foundation Award for Excellence in Clinical Teaching (2018, 2022), and the David A. Rytand Clinical Teaching Award (2018, 2022, and 2025). Dr. Kumar has contributed to the creation of free educational content for POCUS, including videos for the Stanford Medicine 25 series, New England Journal of Medicine, and JAMA, which have amassed over 1,000,000 views worldwide.
Dr. Kumar has held numerous leadership positions that reflect his commitment to advancing medical education and clinical practice. He is also the Co-Founder and Director of the SHAPE Program in the Stanford Internal Medicine Residency Program and Co-Director of Clinical Reasoning at Stanford School of Medicine. He previously served as President for the Society of Hospital Medicine Bay Area and Director of the Rathmann Medical Education Fellowship.
List of publications: https://bit.ly/3eop95i
ClinicalTrials.Gov registration:
https://bit.ly/2TizOmD
https://bit.ly/2zeNBjJ
Media:
https://shorturl.at/rNU46
https://stanfordmedicine.box.com/s/jm3544zdwpihj6bstcv72x76zq9nuzbq
https://bit.ly/33MZa0O
https://bit.ly/3t8HE2u
https://wb.md/2zfjY1N
